These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11857635)

  • 21. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
    Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
    J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total synthesis of cryptophycin analogues via a scaffold approach.
    McCubbin JA; Maddess ML; Lautens M
    Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cytostatic activities of didemnin derivatives.
    Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
    J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD; Zhang X; Mooberry SL; Patterson GM; Moore RE
    Cancer Res; 1994 Jul; 54(14):3779-84. PubMed ID: 7913408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
    Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
    Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.
    Lu K; Dempsey J; Schultz RM; Shih C; Teicher BA
    Cancer Chemother Pharmacol; 2001; 47(2):170-8. PubMed ID: 11269744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
    Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
    J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereospecific synthesis of cryptophycin 1.
    Li LH; Tius MA
    Org Lett; 2002 May; 4(10):1637-40. PubMed ID: 12000261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptophycin anticancer drugs revisited.
    Rohr J
    ACS Chem Biol; 2006 Dec; 1(12):747-50. PubMed ID: 17240971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved total synthesis and structure-activity relationship of arenastatin A, a potent cytotoxic spongean depsipeptide.
    Kobayashi M; Wang W; Ohyabu N; Kurosu M; Kitagawa I
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1598-600. PubMed ID: 7586087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total synthesis of [(2S)-Hiv2]didemnin M.
    Liang B; Vera MD; Joullié MM
    J Org Chem; 2000 Jul; 65(15):4762-5. PubMed ID: 10959892
    [No Abstract]   [Full Text] [Related]  

  • 36. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; Joullié MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological property of carba and 20-deoxo analogues of arenastatin A.
    Murakami N; Wang W; Tamura S; Kobayashi M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1823-6. PubMed ID: 10969977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
    Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
    ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptophycin 1 cellular levels and effects in vitro using L1210 cells.
    Foster BJ; Fortuna M; Media J; Wiegand RA; Valeriote FA
    Invest New Drugs; 1998-1999; 16(3):199-204. PubMed ID: 10360599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
    Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
    Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.